Shares of Cencora Inc. COR shed 6.83% to $283.77 Thursday, on what proved to be an all-around favorable trading session for ...

CONSHOHOCKEN, Pa. (AP) — CONSHOHOCKEN, Pa. (AP) — Cencora, Inc. (COR) on Wednesday reported fiscal second-quarter profit of $717.9 million. On a per-share basis, the Conshohocken, Pennsylvania-based ...

This means that Cencora is outperforming the sector as a whole this year. Intensity Therapeutics Inc. (INTS) is another Medical stock that has outperformed the sector so far this year. Since the ...

In its first-quarter 2025 investor letter, Carillon Eagle Mid Cap Growth Fund highlighted stocks such as Cencora, Inc. (NYSE:COR). Cencora, Inc. (NYSE:COR) is a pharmaceutical products distributor.

Shares of Cencora Inc. COR advanced 1.82% to $286.27 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 2.51% to 5,287.76 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

In its first-quarter 2025 investor letter, Carillon Eagle Mid Cap Growth Fund highlighted stocks such as Cencora, Inc. (NYSE:COR). Cencora, Inc. (NYSE:COR) is a pharmaceutical products distributor.

$60,000 of CENCORA INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "IRA implementation. Drug Shortages ...

Morgan Stanley analyst Erin Wright raised the firm’s price target on Cencora (COR) to $288 from $263 and keeps an Equal Weight rating on the shares. While policy will be “front and center ...

In this article, we are going to take a look at where Cencora, Inc. (NYSE:COR) stands against other stocks that Jim Cramer discusses. On Friday, Mad Money host, Jim Cramer, shared his perspective ...